Update shared on28 Sep 2025
Fair value Decreased 6.39%The decline in Bio-Rad Laboratories’ consensus price target to $310.00 primarily reflects lower future P/E and revenue growth expectations.
What's in the News
- Completed buyback of 2,401,554 shares (8.47% of outstanding) for $662.6 million under program announced July 2023.
- Launched four new Droplet Digital PCR platforms, including the QX Continuum and QX700 series, expanding its product portfolio for research and diagnostic applications following the acquisition of Stilla Technologies.
Valuation Changes
Summary of Valuation Changes for Bio-Rad Laboratories
- The Consensus Analyst Price Target has fallen from $331.17 to $310.00.
- The Future P/E for Bio-Rad Laboratories has fallen from 42.57x to 39.92x.
- The Consensus Revenue Growth forecasts for Bio-Rad Laboratories has fallen slightly from 2.3% per annum to 2.2% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.